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Previous estimates of sudden cardiac death in athletes in the United States have varied widely, and therefore we welcome a recent study by Harmon et al. 1 Using the National Collegiate Athletic Association database and information from the Parent Heart Watch, they found an incidence of 1:43 770 per year over a 5-year period covering a total of 1 969 663 athlete participant-years. They also provided information on the relation between incidence of sudden cardiac death and sex, ethnic background, and type of sport. Male athletes were more than twice as likely as female athletes to die suddenly (1:33 134 versus 1:76 646 per year). The risk was clearly higher among black compared with white athletes (1:17 696 versus 1:58 653 per year). There were also differences in the rate of sudden cardiac death in various athlete subgroups. Athletes with the highest risk were Division I male basketball players (1:3126 per year).
Harmon et al 1 concluded that accurate assessment of sudden cardiac death incidence in the different subgroups is essential to shape appropriate health policy decisions and to develop effective strategies for prevention. What is the value of the ECG in helping us develop those strategies? With this question in mind, we should read the article in the current issue of Circulation addressing the ECG of the athlete. 2 It was written by an international group of experts who compare their recommendations with a recent publication by a group of authors representing the Section of Sports Cardiology of the European Association of Cardiovascular Prevention and Rehabilitation and the Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology. 3 Several authors participated in both publications. Preferably, one would like to know the value of the ECG for risk stratification at the start of, during, and after the career of the athlete. In the present article, 2 the authors concentrate mostly on the preparticipation phase.
After history taking and a physical examination, the 12-lead ECG will lead to the recommendation not to pursue an athletic career in cases of typical ECG patterns, allowing a specific diagnosis, such as hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopathy, long and short QT, and the type 1 Brugada pattern. These patients will be referred to a cardiologist/electrophysiologist for further clinical workup. Further clinical workup should also occur when a ventricular preexcitation pattern or a history of tachycardia is present. However, what should we do when unspecific ECG changes are present and no clear-cut diagnosis is possible? Increased QRS voltage and ST-T segment changes fall into that category.
From the 25-year Italian experience with universal preparticipation ECG screening in large cohorts of athletes engaged in a broad variety of sports, we learned that increased QRS voltage and early repolarization changes in the midprecordial leads are common in the general population of asymptomatic young individuals and are not predictive of an increased risk of malignant ventricular arrhythmias. 4 Then we come to training-related ECG changes. It is essential to make the distinction between physiological and pathological changes during the process of athletic cardiac remodeling. The cardiac morphological and electric changes in trained athletes vary with the athlete's sex, age, race, level of fitness, and type of sport. [5] [6] [7] Among the common physiological and benign trainingrelated ECG changes not requiring further evaluation are a slow heart rate (sinus bradycardia, AV nodal Wenckebach), increased QRS voltage, incomplete right bundle-branch block, and ST-T segment changes, such as early repolarization in the precordial leads, with the greatest ST-segment elevation in V 2 to V 5 . As indicated by Uberoi et al 2 and Corrado et al, 3 ST-segment elevation in those leads with an elevated J point and peaked upright T waves or, in black athletes, a domed ST segment followed by T-wave inversion in leads V 2 through V 4 , is usually consistent with a physiological early repolarization pattern. Uberoi et al 2 mention that the combination of high voltage and abnormal repolarization may precede echocardiographic changes in hypertrophic cardiomyopathy and advise following up such athletes with serial echocardiograms. In the case of ST-segment elevation with T-wave changes in right precordial leads, a Brugada-like ECG pattern has to be excluded. Recently, attention was raised about the development of ventricular fibrillation in people showing J-wave elevation restricted to the inferolateral ECG leads. 8 Subsequent information from long-term epidemiological studies in the general population and athletes revealed that such a pattern has an increased hazard ratio for cardiac death that is too small to provide adequate prediction for screening. 9 -11 During an athletic career, training-unrelated ECG changes may occur that should be followed up by further investigation. They include nonvoltage criteria for left ventricular hypertrophy, such as QRS widening and T-wave inversion, right ventricular hypertrophy, intraventricular and interventricular conduction defects with a QRS Ͼ120 milliseconds, ST-segment depression, and T-wave negativity without ST elevation in Ն2 adjacent ECG leads. 2, 3 Then arrhythmias may occur, requiring further investigation. It was shown recently in elite endurance athletes that right ventricular dilatation was present, 12 and that a reduced right ventricular ejection fraction might be accompanied by complex ventricular arrhythmias of right ventricular origin. 13 Arrhythmias may also happen because of intercurrent infections and the use of performance-enhancing, or recreational, drugs. We are poorly informed what ST-T-segment changes take place under these circumstances. And how is the ECG affected by short or long-term deconditioning? That brings us to the stage after the athletic career. We know about the increased incidence of atrial fibrillation in former endurance athletes when they are between 40 and 50 years of age. 14, 15 We need more information on the role of exerciseinduced myocardial remodeling and its effect on atrial and ventricular size, structure, and function on the genesis of atrial and ventricular arrhythmias. 16 Can they be minimized by correct deconditioning 17 ? An important problem in the evaluation of the value of the ECG in the different stages of the athletic career, apart from questions about age-related changes and costs, is the low incidence of end points such as sudden death, requiring large numbers of participants and the necessity of long-term follow-up. Where should the ECG be positioned in counseling during the career of the athlete? To answer all of these questions, large cohort studies are needed.
A history and physical examination in preparticipation screening, with an ECG only during follow-up of concerning signs, as recommended by the American Heart Association, has been shown not to be cost-effective, because of poor sensitivity and specificity. 18 Baggish et al 19 showed marked improvement in sensitivity by the ECG. They also indicated that in case of ECG abnormalities the echocardiogram could be used as a referee to eliminate false-positive ECGs. In addition, Malhotra et al 20 recently indicated that ECG screening of the US college athlete can uncover significant cardiac pathology not discovered by history and physical at an acceptable cost.
Therefore, the importance of the ECG in the screening of the athlete for recognizing silent cardiovascular disease has been demonstrated, 2, 3, 19, 20 and is advised by the European Society of Cardiology and the International Olympic Committee as part of the routine screening before sports participation.
Worldwide, millions of people are performing sports on a regular basis. Obviously, most of them lack the financial means to pay for an ECG, and it is unlikely that funding will come from elsewhere. Realistically, therefore, an ECG will not be recorded in the majority of sports participants. This implies that in contrast to Italy, in most countries, the possibility of ECG screening will be restricted to those who have shown to be particularly gifted and promising in their sport and are entering a regional or national elite squad. For them, the ECG should be a logical entrance criterion. Then the question arises: How often should the ECG be repeated during the athlete's career? The obvious answer is that ECGs should be repeated when complaints like palpitations, dizziness, or syncope or unexpected changes in performance occur. But what about situations in which these things to not occur? Can the ECG play a role in guiding the training program? We also need more information about cardiovascular complications after the athletic career has ended. Do some athletes develop an ECG profile indicating a greater risk later? After reading the articles by Harmon et al 1 and Uberoi et al, 2 we think that a logical consequence for the United States is to have a preparticipation ECG recorded for all 400 000 college athletes who enter the National Collegiate Athletic Association database next year. A major step would be to also have a sufficiently large control group of nonathletic students matched for age, sex, and race and to follow up both groups long term. In view of the observed incidence of sudden cardiac death in relation to sex, ethnic background, and type of sport, the professional organizations of the different sports should critically analyze how ECG use is handled in guiding their athletes. More work is needed to come to a better understanding of the value of the ECG to protect and guide the athlete.
